A study showed that knockout of myeloid differentiation factor 2 (MD2) and TLR4 genes abrogated liver injury and inflammation in a mouse model of MCD-induced NASH (79). This evidence concerns the gene LY96 and metabolic dysfunction-associated steatohepatitis.